Open AccessRadioactive Stents Delay but Do Not Prevent In-Stent Neointimal Hyperplasia
Author(s) -
I Kay,
Alexander J. Wardeh,
Ken Kozuma,
David P. Foley,
A.H.M. Knook,
Attila Thury,
George Sianos,
Willem J. van der Giessen,
Peter C. Levendag,
Patrick W. Serruys
Publication year - 2001
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.103.1.14
Subject(s) - medicine , neointimal hyperplasia , intravascular ultrasound , restenosis , stent , lumen (anatomy) , myocardial infarction , radiology , population , revascularization , angiography , nuclear medicine , cardiology , surgery , environmental health
Restenosis after conventional stenting is almost exclusively caused by neointimal hyperplasia. Beta-particle-emitting radioactive stents decrease in-stent neointimal hyperplasia at 6-month follow-up. The purpose of this study was to evaluate the 1-year outcome of (32)P radioactive stents with an initial activity of 6 to 12 microCi using serial quantitative coronary angiography and volumetric ECG-gated 3D intravascular ultrasound (IVUS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom